FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

AdvaMed Urges FDA to Narrow Guidance on Device QMS

Advanced Medical Technology Association urges FDA to narrow and clarify a draft guidance on quality management system information, warning that the cu...

latest-news-card-1
Biologics

Moderna/Merck Report Positive Data on Melanoma Vaccine

Moderna and Merck report updated five-year follow-up data that show their personalized mRNA cancer vaccine candidate, intismeran autogene, significant...

latest-news-card-1
Human Drugs

Novo Nordisk Supplements Semaglutide Petition

Novo Nordisk submits to FDA additional studies and analyses it says support its petition asking the agency to act against compounded forms of its sema...

Human Drugs

Objectionable Conditions in Prodrome Sciences BIMO Inspection

FDA warns Temecula, CA-based Prodrome Sciences USA about violations in its conduct of a clinical trial without submitting an IND.

latest-news-card-1
Human Drugs

Guide on Endpoints for Multiple Myeloma Accelerated Approval

FDA posts a draft guidance outlining how drug developers can use minimal residual disease and complete response as primary endpoints in multiple myelo...

latest-news-card-1
Biologics

FDA Seeks More Data on Capricor Cell Therapy

FDA asks Capricor Therapeutics for a full clinical study report from the companys Phase 3 HOPE-3 trial as part of its ongoing BLA review for Deramioce...

latest-news-card-1
Human Drugs

ICH Drug Submission Quality Information Guidance

FDA publishes for review and comment the International Council for Harmonization M4Q(R2) guidance establishing the location and structure of quality i...

latest-news-card-1
Human Drugs

4 CGMP Issues at Integrity Partners Facility

FDA warns Integrity Partners St. Louis, MO-based Chemisphere drug manufacturing facility about CGMP issues in its production of finished drugs as a co...

latest-news-card-1
Biologics

Valneva Withdraws BLA for Chikungunya Vaccine

Valneva says it has voluntarily withdrawn its BLA for Ixchiq, the companys chikungunya vaccine, based on FDA safety-related restrictions on the produc...

latest-news-card-1
Human Drugs

Celcuity NDA Gets Priority Review for Breast Cancer

FDA accepts for priority review a Celcuity NDA for gedatolisib in patients with hormone receptorpositive, HER2-negative, PIK3CA wild-type advanced bre...